FIELD: medicine.
SUBSTANCE: invention relates to casein kinase 1 (CK1) inhibitor, which is PF-670462, for prevention and/or treatment vascular and/or cardiovascular disease, in which myogenic reactivity in the peripheral blood vessel system is disturbed.
EFFECT: use of the invention enables effective treatment and prevention of vascular and cardiovascular diseases in which myogenic reactivity in the peripheral vascular system is impaired.
14 cl, 6 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF CFTR MODULATORS FOR TREATING CEREBROVASCULAR CONDITIONS | 2019 |
|
RU2820288C2 |
| METHOD OF SELECTING THERAPEUTIC APPROACH TO ARTERIAL HYPERTENSION | 2019 |
|
RU2718303C1 |
| METHOD FOR PREDICTING THE FLOW OF PULMONARY HYPERTENSION IN PATIENTS WITH INBORN HEART FAILURES | 2004 |
|
RU2281033C2 |
| METHOD FOR BRAIN RESISTANCE VESSELS DILATATORNOY REACTIVITY DETERMINATION | 2016 |
|
RU2613720C1 |
| METHOD FOR EVALUATING VASCULAR RESERVE OF PERIPHERAL ARTERIES | 2000 |
|
RU2161911C1 |
| USE OF PEPTIDE FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2013 |
|
RU2672341C2 |
| APPLICATION OF DIPEPTIDYLPEPTIDASE IV INHIBITORS | 2004 |
|
RU2385723C2 |
| PHARMACEUTICAL COMPOSITION COMPRISING microRNA-100 AND USE THEREOF IN MODULATING GROWTH OF BLOOD VESSELS AND ENDOTHELIUM INFLAMMATION | 2010 |
|
RU2586531C2 |
| METHOD OF DIAGNOSING TENDENCY TO VASOCONSTRICTION OF PERIPHERAL VASCULAR BED | 2015 |
|
RU2582764C1 |
| METHOD FOR ESTIMATING ENDOTHELIUM-DEPENDENT VASODILATATION OF BRACHIAL ARTERY WITH UNDERLYING REACTIVE HYPERAEMIA | 2008 |
|
RU2371086C1 |
